A COVID-19 infection apparently triggered the development of atypical hemolytic uremic syndrome (aHUS) in a 75-year-old man who had recently received a kidney transplant, according to a case report. Treatment with Ultomiris (ravulizumab) helped resolve his symptoms, supporting the use of the medication post-kidney transplant. Some kidney transplant…